These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24915808)

  • 1. [To improve the quality of pathologic diagnosis through standardized HER2 testing].
    Bu H; Yang W
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):217-8. PubMed ID: 24915808
    [No Abstract]   [Full Text] [Related]  

  • 2. [Guidelines for HER2 detection in breast cancer, the 2014 version].
    Guideline Recommendations for HER2 Detection in Breast Cancer Group
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):262-7. PubMed ID: 24915819
    [No Abstract]   [Full Text] [Related]  

  • 3. Co-amplification of the HER2 gene and chromosome 17 centromere: a potential diagnostic pitfall in HER2 testing in breast cancer.
    Varga Z; Tubbs RR; Wang Z; Sun Y; Noske A; Kradolfer D; Bosshard G; Jochum W; Moch H; Öhlschlegel C
    Breast Cancer Res Treat; 2012 Apr; 132(3):925-35. PubMed ID: 21698407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the 2007 and 2013 ASCO/CAP evaluation systems for HER2 amplification in breast cancer.
    Pu X; Shi J; Li Z; Feng A; Ye Q
    Pathol Res Pract; 2015 Jun; 211(6):421-5. PubMed ID: 25818873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of HER2 overexpression with gene amplification and its relation to chromosome 17 aneuploidy: a 5-year experience with invasive ductal and lobular carcinomas.
    Nassar A; Khoor A; Radhakrishnan R; Radhakrishnan A; Cohen C
    Int J Clin Exp Pathol; 2014; 7(9):6254-61. PubMed ID: 25337277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated CEP17 Copy Number Gain in Invasive Breast Cancer Results in a "Reverse" Amplification Status.
    Van Bockstal MR; Dubois D; Talpe S; Galant C
    Int J Surg Pathol; 2021 Feb; 29(1):76-77. PubMed ID: 32131665
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of fluorescence in situ hybridization (FISH) and dual-ISH (DISH) in the determination of HER2 status in breast cancer.
    Mansfield AS; Sukov WR; Eckel-Passow JE; Sakai Y; Walsh FJ; Lonzo M; Wiktor AE; Dogan A; Jenkins RB
    Am J Clin Pathol; 2013 Feb; 139(2):144-50. PubMed ID: 23355198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization.
    Jimenez RE; Wallis T; Tabasczka P; Visscher DW
    Mod Pathol; 2000 Jan; 13(1):37-45. PubMed ID: 10658908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of rarity of chromosome 17 polysomy in breast cancer.
    Moelans CB; Reis-Filho JS; van Diest PJ
    Lancet Oncol; 2011 Nov; 12(12):1087-9. PubMed ID: 21903472
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnosis of HER2 gene amplification in breast carcinoma].
    Couturier J; Vincent-Salomon A; Mathieu MC; Valent A; Bernheim A
    Pathol Biol (Paris); 2008 Sep; 56(6):375-9. PubMed ID: 18456424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-amplification and co-localization: Rare signal pattern in human epidermal growth factor receptor 2 gene fluorescence
    Gupta A; Patibandla SR; Kasaragadda MR; Goyal M
    Indian J Pathol Microbiol; 2019; 62(2):355-356. PubMed ID: 30971582
    [No Abstract]   [Full Text] [Related]  

  • 12. How is Her-2/neu status established when Her-2/neu and chromosome 17 centromere are both amplified?
    Press MF
    Am J Clin Pathol; 2006 Nov; 126(5):673-4. PubMed ID: 17050063
    [No Abstract]   [Full Text] [Related]  

  • 13. Absence of chromosome 17 polysomy in breast cancer: analysis by CEP17 chromogenic in situ hybridization and multiplex ligation-dependent probe amplification.
    Moelans CB; de Weger RA; van Diest PJ
    Breast Cancer Res Treat; 2010 Feb; 120(1):1-7. PubMed ID: 19760503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordant HER2 immunohistochemical expression and gene amplification in ductal carcinoma in situ - evaluating HER2 in synchronous in-situ and invasive carcinoma.
    Hui Y; Lu S; Wang H; Resnick MB; Wang Y
    Histopathology; 2019 Jan; 74(2):358-362. PubMed ID: 30117181
    [No Abstract]   [Full Text] [Related]  

  • 15. One-day FISH approach for the high-speed determination of HER2 gene copy status in breast carcinoma.
    Hegyi K; Lønborg C; Mónus A; Méhes G
    Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):567-71. PubMed ID: 23455187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral heterogeneity of HER2/neu in breast cancer--a rare event.
    Hanna W; Nofech-Mozes S; Kahn HJ
    Breast J; 2007; 13(2):122-9. PubMed ID: 17319852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HER-2 oncogene amplification assessment in invasive breast cancer by dual-color in situ hybridization (dc-CISH): a comparative study with fluorescent in situ hybridization (FISH)].
    Akhdar A; Bronsard M; Lemieux R; Geha S
    Ann Pathol; 2011 Dec; 31(6):472-9. PubMed ID: 22172120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of HER2 gene status in breast cancer with HER2 protein overexpression].
    Zeng X; Liang ZY; Wu SF; Zhou WX; Gao J; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2006 Oct; 35(10):584-8. PubMed ID: 17134563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is it necessary to evaluate nuclei in HER2 FISH evaluation?
    López C; Tomás B; Korzynska A; Bosch R; Salvadó MT; Llobera M; Garcia-Rojo M; Alvaro T; Jaén J; Lejeune M
    Am J Clin Pathol; 2013 Jan; 139(1):47-54. PubMed ID: 23270898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HER2, chromosome 17 polysomy and DNA ploidy status in breast cancer; a translational study.
    Halilovic A; Verweij DI; Simons A; Stevens-Kroef MJPL; Vermeulen S; Elsink J; Tops BBJ; Otte-Höller I; van der Laak JAWM; van de Water C; Boelens OBA; Schlooz-Vries MS; Dijkstra JR; Nagtegaal ID; Tol J; van Cleef PHJ; Span PN; Bult P
    Sci Rep; 2019 Aug; 9(1):11679. PubMed ID: 31406196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.